The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Gallbladder Cancer in the 21st Century
Open accessAbstract
Gallbladder cancer (GBC) is an uncommon disease in the majority of the world despite being the most common and aggressive malignancy of the biliary tree. Early diagnosis is essential for improved prognosis; however, indolent and nonspecific clinical presentations with a paucity of pathognomonic/predictive radiological features often preclude accurate identification of GBC at an early stage. As such, GBC remains a highly lethal disease, with only 10% of all patients presenting at a stage amenable to surgical resection. Among this select population, continued improvements in survival during the 21st century are attributable to aggressive radical surgery with improved surgical techniques. This paper reviews the current available literature of the 21st century on PubMed and Medline to provide a detailed summary of the epidemiology and risk factors, pathogenesis, clinical presentation, radiology, pathology, management, and prognosis of GBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Gallbladder cancer: epidemiology and outcome
Shaffer, E., & Hundal, R. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37357 · Cited by 1,089
Misra, S., Chaturvedi, A., Misra, N. C., & Sharma, I. D. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01021-0 · Cited by 812
Wolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778 · cited 1×
“09 for men [7, 13].”
Rougier, P., Adenis, A., Ducreux, M., de Forni, M., Bonneterre, J., Dembak, M., Clouet, P., Lebecq, A., Baille, P., Lefresne-Soulas, F., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00072-1 · Cited by 751
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Horgan, A. M., Amir, E., Walter, T., & Knox, J. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.5381 · Cited by 716
Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract, Takada, T., Amano, H., Yasuda, H., Nimura, Y., Matsushiro, T., Kato, H., Nagakawa, T., & Nakayama, T. (2002) · Cancer · doi:10.1002/cncr.10831 · Cited by 631
Lee, J., Park, S. H., Chang, H.-M., Kim, J. S., Choi, H. J., Lee, M. A., Chang, J. S., Jeung, H. C., Kang, J. H., Lee, H. W., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70301-1 · Cited by 478
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
Eckel, F., & Schmid, R. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603648 · Cited by 464
Li, M., Zhang, Z., Li, X., Ye, J., Wu, X., Tan, Z., Liu, C., Shen, B., Wang, X.-A., Wu, W., et al. (2014) · Nature Genetics · doi:10.1038/ng.3030 · Cited by 443
André, T., Tournigand, C., Rosmorduc, O., Provent, S., Maindrault-Goebel, F., Avenin, D., Selle, F., Paye, F., Hannoun, L., Houry, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh351 · Cited by 380
Current Management of Gallbladder Carcinoma
Zhu, A. X., Hong, T. S., Hezel, A. F., & Kooby, D. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0302 · Cited by 343
Carcinoma of the gallbladder. Staging, treatment, and prognosis
Nevin, J., Moran, T. J., Kay, S., & King, R. E. (1976) · Cancer · Cited by 321
Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial
Knox, J. J., Hedley, D. W., Oza, A. M., Feld, R., Siu, L. L., Chen, E. X., Nematollahi, M., Pond, G. R., Zhang, J., & Moore, M. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.51.008 · Cited by 305
Zhu, A. X., Meyerhardt, J. A., Blaszkowsky, L. S., Kambadakone, A. R., Muzikansky, A., Zheng, H., Clark, J. W., Abrams, T. A., Chan, J. A., Enzinger, P. C., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70333-x · Cited by 303
Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
Bekaii-Saab, T., Phelps, M. A., Li, X., Saji, M., Goff, L., Kauh, J. S. W., O'Neil, B. H., Balsom, S., Balint, C., Liersemann, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.9473 · Cited by 303
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H.-J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., Mack, P. C., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0927-7 · Cited by 284
Lubner, S. J., Mahoney, M. R., Kolesar, J. L., LoConte, N. K., Kim, G. P., Pitot, H. C., Philip, P. A., Picus, J., Yong, W.-P., Horvath, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4075 · Cited by 267
Gruenberger, B., Schueller, J., Heubrandtner, U., Wrba, F., Tamandl, D., Kaczirek, K., Roka, R., Freimann-Pircher, S., & Gruenberger, T. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70247-3 · Cited by 247
Stein, A., Arnold, D., Bridgewater, J., Goldstein, D., Jensen, L. H., Klümpen, H.-J., Lohse, A. W., Nashan, B., Primrose, J., Schrum, S., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1498-0 · Cited by 238
Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder Cancer
Wang, S. J., Lemieux, A., Kalpathy-Cramer, J., Ord, C. B., Walker, G. V., Fuller, C. D., Kim, J.-S., & Thomas, C. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8020 · Cited by 217
Miller, G., & Jarnagin, W. R. (2008) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2007.07.206 · Cited by 211
Genetics of Biliary Tract Cancers and Emerging Targeted Therapies
Hezel, A. F., Deshpande, V., & Zhu, A. X. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4787 · Cited by 210
Patt, Y. Z., Hassan, M. M., Aguayo, A., Nooka, A. K., Lozano, R. D., Curley, S. A., Vauthey, J., Ellis, L. M., Schnirer, I. I., Wolff, R. A., et al. (2004) · Cancer · doi:10.1002/cncr.20368 · Cited by 203
Gallbladder cancer — A comprehensive review
Lai, C. H. E., & Lau, W. Y. (2008) · The Surgeon · doi:10.1016/s1479-666x(08)80073-x · Cited by 202
Gallbladder cancer: a morphological and molecular update
Goldin, R. D., & Roa, J. C. (2009) · Histopathology · doi:10.1111/j.1365-2559.2008.03192.x · Cited by 197
Foo, M. L., Gunderson, L. L., Bender, C. E., & Buskirk, S. J. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00299-x · Cited by 175
El-Khoueiry, A. B., Rankin, C. J., Ben-Josef, E., Lenz, H.-J., Gold, P. J., Hamilton, R. D., Govindarajan, R., Eng, C., & Blanke, C. D. (2012) · Investigational New Drugs · doi:10.1007/s10637-011-9719-0 · Cited by 160
Thongprasert, S., Napapan, S., Charoentum, C., & Moonprakan, S. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi046 · Cited by 141
Gallbladder cancer: Can newer insights improve the outcome?
Dutta, U. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07048.x · Cited by 134
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
Harder, J., Riecken, B., Kummer, O., Lohrmann, C., Otto, F., Usadel, H., Geißler, M., OPITZ, O. G., & Henß, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603334 · Cited by 133
Nehls, O., Oettle, H., Hartmann, J. T., Hofheinz, R.-D., Hass, H. G., Horger, M., Koppenhöfer, U., Hochhaus, A., Stieler, J., Trojan, J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604178 · Cited by 125
Mayo, S. C., Shore, A. D., Nathan, H., Edil, B. H., Wolfgang, C. L., Hirose, K., Herman, J. M., Schulick, R. D., Choti, M. A., & Pawlik, T. M. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1335-3 · Cited by 118
Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma
Alberts, S. R., Alkhatib, H., Mahoney, M. R., et al. (2004) · Cancer · doi:10.1002/cncr.20753 · Cited by 116
Weekly Gemcitabine for the Treatment of Biliary Tract and Gallbladder Cancer
Tsavaris, N. B., Kosmas, C., Gouveris, P., Gennatas, K., Polyzos, A., Mouratidou, D., Tsipras, H., Margaris, H., Papastratis, G., Tzima, E., et al. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000011797.09549.53 · Cited by 100
Molecular Events in Primary and Metastatic Colorectal Carcinoma: A Review
Kanthan, R., Senger, J. B., & Kanthan, S. C. (2012) · Pathology Research International · doi:10.1155/2012/597497 · Cited by 100
Self-citationRisk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates
Rustagi, T., & Dasanu, C. A. (2011) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-011-9284-y · Cited by 94
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Eckel, F., Brunner, T. B., & Jelić, S. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq167 · Cited by 93
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Eckel, F., Brunner, T. B., & Jelić, S. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr375 · Cited by 89
Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.
Jones, D. V., Lozano, R. D., Hoque, A. M., Markowitz, A., & Patt, Y. Z. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2306 · Cited by 87
Sakata, J., Shirai, Y., Wakai, T., Ajioka, Y., & Hatakeyama, K. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0899-1 · Cited by 82
Is port-site resection necessary in the surgical management of gallbladder cancer?
Fuks, D., Regimbeau, J., Pessaux, P., Bachellier, P., Raventos, A., Mantion, G., Gigot, J.-F., Chiche, L., Pascal, G., Azoulay, D., et al. (2013) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2013.03.006 · Cited by 77
Ability of FDG‐PET/CT in the detection of gallbladder cancer
Ramos-Font, C., Gómez-Río, M. M., Fernández, A. R., Jiménez‐Heffernan, A., Sánchez, R. S., & Elvira, J. M. L. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23476 · Cited by 73
Growth rate and malignant potential of small gallbladder polyps – Systematic review of evidence
Wiles, R., Varadpande, M., Muly, S., & Webb, J. (2014) · The Surgeon · doi:10.1016/j.surge.2014.01.003 · Cited by 60
Cariati, A., Piromalli, E., & Cetta, F. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000074 · Cited by 55
Papakostas, P., Kouroussis, C., Androulakis, N., Samelis, G. F., Aravantinos, G., Kalbakis, K., Sarra, E., Souglakos, J., Kakolyris, S., & Georgoulias, V. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00214-3 · Cited by 54
Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder
Lee, N. K., Kim, S., Kim, T. U., Kim, D. U., Seo, H. I., & Jeon, T. Y. (2013) · Clinical Radiology · doi:10.1016/j.crad.2013.09.017 · Cited by 53
Kim, S., Lee, J. M., Kim, H., Yoon, J. H., Han, J. K., & Choi, B. I. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23956 · Cited by 53
Roa, J. C., Tapia, Ó., Manterola, C., Villaseca, M., Guzmán, P., Araya, J. C., Bağcı, P., Saka, B., & Adsay, V. N. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1478-1 · Cited by 51
Jin, K., Lan, H., Zhu, T., He, K., & Teng, L. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0613-1 · Cited by 41
Letelier, P. J., García, P., Leal, P., Ili, C., Buchegger, K., Riquelme, I., Sandoval, A., Tapia, Ó., & Roa, J. C. (2013) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3182a318a9 · Cited by 36
Microsatellite instability in gallbladder carcinoma
Moy, A. P., Shahid, M., Ferrone, C. R., Borger, D. R., Zhu, A. X., Ting, D. T., & Deshpande, V. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1720-0 · Cited by 34
Yi, S., Yang, Z., Miao, X., Zou, Q., Li, J., Liang, L., Zeng, G., & Chen, S. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.01.014 · Cited by 33
Polyp on Ultrasound: Now What? The Association between Gallbladder Polyps and Cancer
Donald, G. W., Sunjaya, D. B., Donahue, T. R., & Hines, O. J. (2013) · The American Surgeon · doi:10.1177/000313481307901010 · Cited by 32
State-of-the-art in the management of locally advanced and metastatic gallbladder cancer
McNamara, M. G., Metran-Nascente, C., & Knox, J. J. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283620fd8 · Cited by 29
Zou, Q., Xiong, L., Yang, Z., Lv, F., Yang, L., & Miao, X. (2012) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-10-92 · Cited by 29
Zhang, Y., Huang, Y. L., & Qin, M. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12109 · Cited by 27
Prince, S., Zeidman, A., Dekel, Y., Ram, E., & Koren, R. (2008) · American Journal of Clinical Pathology · doi:10.1309/h8jeeaeb69j3kynd · Cited by 27
Primary carcinoid tumor of the gallbladder: A case report and brief review of the literature
Zou, Y., Li, W., Liu, H., & Li, N. (2010) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-8-12 · Cited by 20
Epigenetic Changes in Carcinogenesis of Gallbladder
Tewari, M., Agarwal, A., Mishra, R. R., Meena, R. N., & Shukla, H. S. (2013) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-013-0240-0 · Cited by 17
Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers
Rohrberg, K. S., Olesen, R. K., Pfeiffer, P., Ladekarl, M. B., Pappot, H., Christensen, I. J., Høyer‐Hansen, G., Mau‐Sørensen, M., Skov, B. G., Buysschaert, I., et al. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.619568 · Cited by 16
Yang, Z., Yang, Z., Xiong, L., Huang, S., Liu, J., Yang, L., & Miao, X. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e318212f001 · Cited by 10
Cited by
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Sun, L., Cai, J., & Gonzalez, F. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00404-2 · Cited by 435
Metadata
- Authors
- Kanthan, R., Senger, J.-L., Ahmed, S., & Kanthan, S. C.
- Venue
- Journal of Oncology
- Publisher
- Hindawi Limited
- Published
- 2015
- Volume
- 2015
- Pages
- 1-26
- ISSN
- 1687-8450 (ISSN-L)
- 1687-8469
- OpenAlex
- W1665091651
- Cited by
- 295
- References
- 63
- FWCI
- 23.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.